SCI Pharmtech Dividends and Buybacks
Dividend criteria checks 1/6
SCI Pharmtech is a dividend paying company with a current yield of 1.39% that is well covered by earnings.
Key information
1.4%
Dividend yield
-8.9%
Buyback Yield
| Total Shareholder Yield | -7.5% |
| Future Dividend Yield | 1.4% |
| Dividend Growth | -24.5% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | NT$1.250 |
| Payout ratio | 31% |
Recent dividend and buyback updates
Recent updates
Shareholders Shouldn’t Be Too Comfortable With SCI Pharmtech's (TWSE:4119) Strong Earnings
Nov 17
We Think That There Are More Issues For SCI Pharmtech (TWSE:4119) Than Just Sluggish Earnings
Mar 27Analysts Just Shipped A Captivating Upgrade To Their SCI Pharmtech, Inc. (TPE:4119) Estimates
Apr 07There May Be Reason For Hope In SCI Pharmtech's (TPE:4119) Disappointing Earnings
Mar 30SCI Pharmtech, Inc. (TPE:4119) Is Yielding 6.3% - But Is It A Buy?
Mar 08SCI Pharmtech (TPE:4119) Shareholders Booked A 54% Gain In The Last Three Years
Jan 25
Some SCI Pharmtech, Inc. (TPE:4119) Analysts Just Made A Major Cut To Next Year's Estimates
Dec 30Declining Stock and Solid Fundamentals: Is The Market Wrong About SCI Pharmtech, Inc. (TPE:4119)?
Dec 29Would SCI Pharmtech, Inc. (TPE:4119) Be Valuable To Income Investors?
Dec 08A Look At The Intrinsic Value Of SCI Pharmtech, Inc. (TPE:4119)
Nov 17Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 4119's dividend payments have been volatile in the past 10 years.
Growing Dividend: 4119's dividend payments have fallen over the past 10 years.
Dividend Yield vs Market
| SCI Pharmtech Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (4119) | 1.4% |
| Market Bottom 25% (TW) | 1.8% |
| Market Top 25% (TW) | 4.5% |
| Industry Average (Pharmaceuticals) | 2.3% |
| Analyst forecast (4119) (up to 3 years) | 1.4% |
Notable Dividend: 4119's dividend (1.39%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (1.77%).
High Dividend: 4119's dividend (1.39%) is low compared to the top 25% of dividend payers in the TW market (4.52%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (30.6%), 4119's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 4119 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 23:37 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SCI Pharmtech, Inc. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yenya Kuo | Capital Securities Corporation |
| Regina Lee | IBTS Investment Consulting Co., Ltd. |
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |